AI
Monday, June 16, 2014 10:49:33 PM
blue:
Thats about 100 million market cap per patient. Thats a pretty good market cap increase per patient
.
I don't follow them closely so can't make a comment on whether its justified or not. I am curious though what type of long term safety data the FDA may want to see (BMRN has a gene therapy program with big market potential). Does anyone know if there is even guidance out on that?
Thats about 100 million market cap per patient. Thats a pretty good market cap increase per patient
. I don't follow them closely so can't make a comment on whether its justified or not. I am curious though what type of long term safety data the FDA may want to see (BMRN has a gene therapy program with big market potential). Does anyone know if there is even guidance out on that?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
